FDA Adverse Event Injury Summary report: N

EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE

MDR report key: 11083316 · Received December 28, 2020

Report

Report Number
2015691-2020-15303
Event Type
Injury
Date Received
December 28, 2020
Date of Event
December 1, 2020
Report Date
November 13, 2023
Manufacturer
EDWARDS LIFESCIENCES
Product Code
NPT
PMA / PMN Number
P140031
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CITATION: HONG, N. C., ET AL. ''TRANSCATHETER AORTIC VALVE REPLACEMENT WITH ANTEROGRADE GUIDE WIRE THROUGH ATRIAL SEPTUM IN 2 PATIENTS WITH SEVERE AORTIC STENOSIS POST TRANSCATHETER OR SURGICAL AORTIC VALVE REPLACEMENT.'' ZHONGHUA XIN XUE GUAN BING ZA ZHI 50.5 (2022): 509-511. CORRECTED B.7 AND D6A BASED ON INFORMATION DISCOVERED IN THE ARTICLE REFERENCED ABOVE.

Additional Manufacturer Narrative · 1

UDI: (B)(4); INVESTIGATION IS ONGOING. THIS INDIVIDUAL REPORT PROVIDES DATA RECEIVED FROM THE THV/TVT REGISTRY.

Description of Event or Problem · 1

AS REPORTED BY THE EDWARDS EUROPEAN AFFILIATE, 10 MONTHS AFTER IMPLANTATION OF A 20MM SAPIEN 3 VALVE, THE PATIENT BEGAN TO SUFFER FROM SEVERE ANGINA. CARDIAC ECHOCARDIOGRAPHY SHOWED AOV PEAK VELOCITY 430 CM/S, AOV PEAK GRADIENT 74 MMHG AND AOV MEAN GRADIENT OF 39 MMHG. PATIENT WAS HOSPITALIZED DUE TO CHEST PAIN. TREATMENT INVOLVED ANTICOAGULATION THERAPY, AS PHYSICIAN SUSPECTS VALVE THROMBOSIS AS ROOT CAUSE OF AORTIC VALVE STENOSIS. A VIV PROCEDURE WAS PERFORMED WITH A SELF-EXPANDABLE NON-EDWARDS VALVE. THROMBOSIS WAS CONFIRMED AS THE ROOT CAUSE AND THE PATIENT WAS IN GOOD CONDITION AND STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1549382 EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT EDWARDS LIFESCIENCES 9600TFX20 5731788

Patients

Seq Age Sex Outcome Treatment
1 73 YR Unknown Hospitalization| R